Home Biosimilar Antibodies Immunology & Inflammation CD markers antibody Encelimab (Anti-LAG3 / CD223) For research use only.
Not for use in humans.

Encelimab (Anti-LAG3 / CD223)

Synonyms: TSR 033

Encelimab (Anti-LAG3 / CD223) is a humanized monoclonal antibody targeting the inhibitory receptor lymphocyte activation gene 3 protein (LAG3). It has potential immune checkpoint inhibitory and antineoplastic, antitumor activity. MW :144.58 KD.

Encelimab (Anti-LAG3 / CD223)

Purity & Quality Control

≥99

Choose Selective CD markers Inhibitors

Biological Activity

Description Encelimab (Anti-LAG3 / CD223) is a humanized monoclonal antibody targeting the inhibitory receptor lymphocyte activation gene 3 protein (LAG3). It has potential immune checkpoint inhibitory and antineoplastic, antitumor activity. MW :144.58 KD.

Product Details

CAS No. 2173096-82-5
Molecular Weight 144.58
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Encelimab (Anti-LAG3 / CD223) | Encelimab (Anti-LAG3 / CD223) supplier | purchase Encelimab (Anti-LAG3 / CD223) | Encelimab (Anti-LAG3 / CD223) cost | Encelimab (Anti-LAG3 / CD223) manufacturer | order Encelimab (Anti-LAG3 / CD223) | Encelimab (Anti-LAG3 / CD223) distributor